Remove 2023 Remove Leads Remove Medical science Remove Pharma
article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). And in 2023, these investments will hopefully pay off. Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”.

Marketing 102
article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. Previously, he spent more than 10 years at Roche in multiple positions within medical affairs. cited 2023 Apr 4]. 2019 [cited 2023 Apr 4]. cited 2023 Apr 4].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

This cookie-less marketing yields promising results with an 84% reduction in cost per acquisitions (CPAs) and a 3x increase in impressions served when compared to leading contextual solutions. These include text and code generation, automated lead generation, music composition, and even personalized speech and video creation.

article thumbnail

The (inevitable) digital transformation of Medical Affairs

Impetus Digital

Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. In 2023, we will see MA engage both patients and payers more than in previous years. This offers new opportunities to engage with stakeholders beyond just physicians.

Medical 52
article thumbnail

Imagene Profiles Cancer Biomarkers in Real Time

Medgadget

Thanks to support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below about the upcoming event), we had a chance to learn about Imagene’s technology from Dean Bitan, CEO and Co-Founder of the company. More info can be found at the Biomed Israel website.